NewsBenzinga트루이스트 증권, 젠맙 투자의견 ‘매수’ 재확인···목표주가 67달러로 상향 트루이스트 증권, 젠맙 투자의견 ‘매수’ 재확인···목표주가 67달러로 상향 Benzinga 2026.10.29 15:00 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report